Jeffrey Stein
2022
In 2022, Jeffrey Stein earned a total compensation of $1.3M as President and Chief Executive Officer at Cidara Therapeutics, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $298,600 |
|---|---|
| Option Awards | $173,943 |
| Salary | $565,500 |
| Stock Awards | $209,755 |
| Other | $9,150 |
| Total | $1,256,948 |
Stein received $565.5K in salary, accounting for 45% of the total pay in 2022.
Stein also received $298.6K in non-equity incentive plan, $173.9K in option awards, $209.8K in stock awards and $9.2K in other compensation.
Rankings
In 2022, Jeffrey Stein's compensation ranked 2,594th out of 5,760 executives tracked by ExecPay. In other words, Stein earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,594 out of 5,760 | 55th |
Division Manufacturing | 1,439 out of 3,136 | 54th |
Major group Chemicals And Allied Products | 654 out of 1,422 | 54th |
Industry group Drugs | 607 out of 1,323 | 54th |
Industry Biological Products, Except Diagnostic Substances | 151 out of 291 | 48th |
Source: SEC filing on April 27, 2023.
Stein's colleagues
We found two more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2022.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019